Generalized System of Preferences: Possible Modifications, 2015 Review, 2904-2907 [2016-00771]
Download as PDF
<![CDATA[
2904
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
of the final phase of its investigation.
The Commission will issue a final phase
notice of scheduling, which will be
published in the Federal Register as
provided in section 207.21 of the
Commission’s rules, upon notice from
the Department of Commerce
(‘Commerce’’) of an affirmative
preliminary determination in the
investigation under section 733(b) of the
Act, or, if the preliminary determination
is negative, upon notice of an
affirmative final determination in that
investigation under section 735(a) of the
Act. Parties that filed entries of
appearance in the preliminary phase of
the investigation need not enter a
separate appearance for the final phase
of the investigation. Industrial users,
and, if the merchandise under
investigation is sold at the retail level,
representative consumer organizations
have the right to appear as parties in
Commission antidumping and
countervailing duty investigations. The
Secretary will prepare a public service
list containing the names and addresses
of all persons, or their representatives,
who are parties to the investigation.
Background
On June 25, 2015, American HFC
Coalition, and its members: Amtrol,
Inc., West Warwick, Rhode Island;
Arkema, Inc., King of Prussia,
Pennsylvania; The Chemours Company
FC LLC, Wilmington, Delaware;
Honeywell International Inc.,
Morristown, New Jersey; Hudson
Technologies, Pearl River, New York;
Mexichem Fluor Inc., St. Gabriel,
Louisiana; Worthington Industries, Inc.,
Columbus, Ohio; and District Lodge 154
of the International Association of
Machinists and Aerospace Workers filed
a petition with the Commission and
Commerce, alleging that an industry in
the United States is materially injured
by reason of LTFV imports of
hydrofluorocarbon blends and
components from China. Accordingly,
effective July 2, 2015, the Commission,
pursuant to section 733(a) of the Tariff
Act of 1930 (19 U.S.C. 1673b(a)),
instituted antidumping duty
investigation No. 731–TA–1279
(Preliminary).
Notice of the institution of the
Commission’s investigation and of a
public conference to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register of July 2, 2015 (80 FR
38231). The conference was held in
Washington, DC, on July 16, 2015, and
all persons who requested the
VerDate Sep<11>2014
17:50 Jan 15, 2016
Jkt 238001
opportunity were permitted to appear in
person or by counsel.
The Commission made this
determination pursuant to section
733(a) of the Tariff Act of 1930 (19
U.S.C. 1673b(a)). It completed and filed
its determination in this investigation
on August 10, 2015. The views of the
Commission are contained in USITC
Publication 4558 (August 2015), entitled
Hydrofluorocarbon Blends and
Components from China: Investigation
No. 731–TA–1279 (Preliminary).
By order of the Commission.
Dated: August 11, 2015.
William R. Bishop,
Supervisory Hearings and Information
Officer.
EDITORIAL NOTE: This document was
received for publication by the Office of
the Federal Register on January 13,
2016.
[FR Doc. 2016–00874 Filed 1–15–16; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 332–556]
Generalized System of Preferences:
Possible Modifications, 2015 Review
United States International
Trade Commission.
ACTION: Notice of institution of
investigation and scheduling of public
hearing.
AGENCY:
Following receipt of a request
on December 30, 2015, from the United
States Trade Representative (USTR), the
U.S. International Trade Commission
(Commission) instituted investigation
No. 332–556, Generalized System of
Preferences: Possible Modifications,
2015 Review, for the purpose of
providing advice and information
relating to the possible designation of
additional articles, removal of articles,
and waiver of competitive need
limitations.
SUMMARY:
DATES:
February 1, 2016: Deadline for filing
requests to appear at the public hearing.
February 3, 2016: Deadline for filing
pre-hearing briefs and statements.
February 24, 2016: Public hearing.
February 29, 2016: Deadline for filing
post-hearing briefs and statements.
February 29, 2016: Deadline for filing
all other written submissions.
April 28, 2016: Transmittal of
Commission report to the United States
Trade Representative.
ADDRESSES: All Commission offices,
including the Commission’s hearing
rooms, are located in the United States
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
International Trade Commission
Building, 500 E Street SW., Washington,
DC. All written submissions should be
addressed to the Secretary, United
States International Trade Commission,
500 E Street SW., Washington, DC
20436. The public record for this
investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://www.usitc.gov/secretary/
edis.htm.
FOR FURTHER INFORMATION CONTACT:
Information specific to this investigation
may be obtained from Mahnaz Khan,
Project Leader, Office of Industries
(202–205–2046 or mahnaz.khan@
usitc.gov), Jessica Pugliese, Deputy
Project Leader, Office of Industries
(202–205–3064 or jessica.pugliese@
usitc.gov), or Cynthia Foreso, Technical
Advisor, Office of Industries (202–205–
3348 or cynthia.foreso@usitc.gov). For
information on the legal aspects of this
investigation, contact William Gearhart
of the Commission’s Office of the
General Counsel (202–205–3091 or
william.gearhart@usitc.gov). The media
should contact Margaret O’Laughlin,
Office of External Relations (202–205–
1819 or margaret.olaughlin@usitc.gov).
Hearing-impaired individuals may
obtain information on this matter by
contacting the Commission’s TDD
terminal at 202–205–1810. General
information concerning the Commission
may also be obtained by accessing its
Web site (https://www.usitc.gov). Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at 202–205–2000.
Background
In his letter, the USTR requested the
advice and information described
below.
(1) Advice concerning the probable
economic effect of elimination of U.S.
import duties on certain articles from all
beneficiary developing countries under
the GSP program. In accordance with
sections 503(a)(1)(A), 503(e), and 131(a)
of the Trade Act of 1974, as amended
(‘‘the 1974 Act’’) (19 U.S.C.
2463(a)(1)(A), 2463(e), and 2151(a)), and
pursuant to the authority of the
President delegated to the USTR by
sections 4(c) and 8(c) and (d) of
Executive Order 11846 of March 31,
1975, as amended, and pursuant to
section 332(g) of the Tariff Act of 1930
(19 U.S.C. 1332(g)), the USTR notified
the Commission that the articles
identified in Table A of the Annex to
the USTR request letter are being
considered for designation as eligible
articles for purposes of the GSP
program. The USTR requested that the
E:\FR\FM\19JAN1.SGM
19JAN1
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
Commission provide its advice as to the
probable economic effect on total U.S.
imports, U.S. industries producing like
or directly competitive articles, and on
U.S. consumers of the elimination of
U.S. import duties on the articles
identified in Table A of the Annex to
the USTR request letter for all
beneficiary developing countries under
the GSP program (see Table A below).
(2) Advice concerning the probable
economic effect of elimination of U.S.
import duties on certain handbags and
travel goods products for leastdeveloped beneficiary developing
countries (LDBDCs) and certain African
Growth and Opportunity (AGOA)
countries. In accordance with sections
503(a)(1)(B), 503(e), 506A(b)(1), and
131(a) of the 1974 Act, and pursuant to
the authority of the President delegated
to the USTR by sections 4(c) and 8(c)
and (d) of Executive Order 11846 of
March 31, 1975, as amended, and
pursuant to section 332(g) of the Tariff
Act of 1930, the USTR notified the
Commission that certain handbags and
travel goods products identified in
Table A of the Annex to the USTR
request letter are also being considered
for designation as eligible articles for
countries designated as least-developed
beneficiary developing countries
2905
(LDBDCs) and for countries listed in
section 107 of the African Growth and
Opportunity Act (AGOA) (19 U.S.C.
3706). The USTR requested that the
Commission provide its advice as to the
probable economic effect on total U.S.
imports, U.S. industries producing like
or directly competitive articles, and on
U.S. consumers of the elimination of
U.S. import duties on certain handbag
and travel goods products identified in
Table A for LDBDCs, AGOA beneficiary
developing countries, and both LDBDCs
and AGOA beneficiary developing
countries combined under the GSP
program (see Table A below).
TABLE A—POSSIBLE ADDITIONS TO THE LIST OF PRODUCTS ELIGIBLE FOR THE GSP ELIGIBLE PRODUCTS
HTS Subheading or statistical reporting number
Brief description
2204.21.20 ..........................................................
3301.13.00 ..........................................................
7202.11.50 ..........................................................
Effervescent wine .............................................
Essential oils of lemon .....................................
Ferromanganese containing by weight more
than 4 percent of carbon.
Certain handbags and travel goods products
4202.11.00; 4202.11.00.30; 4202.11.00.90;
4202.12.40;
4202.21.60;
4202.21.90;
4202.22.15;
4202.22.45;
4202.31.60;
4202.32.40;
4202.32.80;
4202.92.15;
4202.92.20;
4202.92.45;
4202.99.90;
4202.12.20.20;
4202.12.20.50;
4202.12.80.30;
4202.12.80.70;
4202.22.80.50;
4202.32.95.50;
4202.32.95.60; 4202.91.00.30; 4202.91.00.90.
(3) Advice concerning the probable
economic effect of removal of certain
articles from specified countries from
eligibility for duty-free treatment. The
USTR notified the Commission that
certain articles are being considered for
removal from eligibility for duty free
treatment under the GSP program from
Country(ies)
specified countries. Under authority
delegated by the President, pursuant to
section 332(g) of the Tariff Act of 1930,
with respect to articles listed in Table B
of the Annex to the USTR request letter,
the USTR requested that the
Commission provide its advice as to the
probable economic effect of the removal
Beneficiary Developing Countries.
Beneficiary Developing Countries.
Beneficiary Developing Countries.
Beneficiary Developing Countries, Less Developed Beneficiary Developing countries,
and AGOA countries.
from eligibility for duty-free treatment
under the GSP program for such articles
from the specified country on total U.S.
imports, U.S. industries producing like
or directly competitive articles, and on
U.S. consumers (see Table B below).
TABLE B—POSSIBLE REMOVALS FROM DUTY-FREE STATUS FROM THE SPECIFIED COUNTRY FOR A PRODUCT ON THE LIST
OF ELIGIBLE ARTICLES FOR THE GSP
HTS Subheading
3204.20.10
3204.20.80
3907.60.00
3920.62.00
...........................
...........................
...........................
...........................
asabaliauskas on DSK5VPTVN1PROD with NOTICES
3921.90.40 ...........................
Brief description
Fluorescent brightening agent 32 ...................................
Other fluorescent brightening agents ..............................
PET resin (polyethylene terephthalate in primary forms)
Nonadhesive plates, sheets, film, foil and strip, noncellular, of polyethylene terephthalate.
Nonadhesive plates, sheets, film, foil and strip, flexible,
nesoi, of noncellular plastics.
(4) Advice concerning waiver of
certain competitive need limitations.
Under authority delegated by the
President, pursuant to section 332(g) of
the Tariff Act of 1930, and in
accordance with section 503(d)(1)(A) of
the 1974 Act, the USTR requested that
the Commission provide advice on
whether any industry in the United
States is likely to be adversely affected
VerDate Sep<11>2014
17:50 Jan 15, 2016
Country
Jkt 238001
India and Indonesia.
India and Indonesia.
India.
Brazil.
Brazil.
by a waiver of the competitive need
limitations specified in section
503(c)(2)(A) of the 1974 Act for the
countries and articles specified in Table
C of the attached Annex to the request
letter (see Table C below). Further, in
accordance with section 503(c)(2)(E) of
the 1974 Act, the USTR requested that
the Commission provide its advice with
respect to whether like or directly
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
competitive products were being
produced in the United States on
January 1, 1995. The USTR also
requested that the Commission provide
its advice as to the probable economic
effect on total U.S. imports, as well as
on consumers, of the requested waivers.
With respect to the competitive need
limit in section 503(c)(2(A)(i)(I) of the
1974 Act, the USTR requested that the
E:\FR\FM\19JAN1.SGM
19JAN1
2906
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
Commission use the dollar value limit
of $170,000,000.
TABLE C—POSSIBLE WAIVERS OF THE CNL FROM A SPECIFIC COUNTRY
HTS Subheading
Brief description
0804.10.60 ...........................
Dates, fresh or dried, whole, without pits, packed in
units weighing over 4.6 kg.
Virgin olive oil and its fractions, whether or not refined,
not chemically modified, weighing with the immediate
container 18 kg or over.
Single-cell micro-organisms, dead, excluding yeasts,
(but not including vaccines of heading 3002).
Nonalcoholic beverages, nesi, not including fruit or vegetable juices of heading 2009.
Rare gases, other than argon .........................................
Insulated beverage bag w/outer surface textiles, interior
only flexible plastic container storing/dispensing beverage thru flexible tubing.
Porcelain or china (o/than bone china) household table
& kitchenware in sets in which aggregate val. of arts./
U.S. note 6(b) o/$56 n/o $200.
Parts & accessories of motor vehicle of 8701, nesoi,
8702 and 8704–8705, half-shafts.
1509.10.40 ...........................
2102.20.60 ...........................
2202.90.90 ...........................
2804.29.00 ...........................
4202.92.04 ...........................
6911.10.37 ...........................
8708.50.95 ...........................
Time for reporting, HTS detail,
portions of report to be classified. As
requested by the USTR, the Commission
will provide the requested advice and
information by April 28, 2016. The
USTR asked that the Commission issue,
as soon as possible thereafter, a public
version of the report containing only the
unclassified information, with any
confidential business information
deleted. As requested, the Commission
will provide its advice and statistics
(profile of the U.S. industry and market
and U.S. import and export data) and
any other relevant information or advice
separately and individually for each
U.S. Harmonized Tariff Schedule
subheading for all products subject to
the request. The USTR indicated that
those sections of the Commission’s
report and working papers that contain
the Commission’s advice and
assessment will be classified as
‘‘confidential.’’ The USTR also stated
that his office considers the
Commission’s report to be an interagency memorandum that will contain
pre-decisional advice and be subject to
the deliberative process privilege.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Public Hearing
A public hearing in connection with
this investigation will be held at the
U.S. International Trade Commission
Building, 500 E Street SW., Washington,
DC, beginning at 9:30 a.m. on February
24, 2016. Requests to appear at the
public hearing should be filed with the
Secretary no later than 5:15 p.m.,
February 1, 2016. All pre-hearing briefs
and statements should be filed no later
than 5:15 p.m., February 3, 2016; and all
post-hearing briefs and statements
VerDate Sep<11>2014
17:50 Jan 15, 2016
Jkt 238001
Country
Tunisia.
Tunisia.
Brazil.
Thailand.
Ukraine.
Philippines.
Indonesia.
India.
should be filed no later than 5:15 p.m.,
February 29, 2016. All requests to
appear, and pre- and post-hearing briefs
and statements should be filed in
accordance with the requirements of the
‘‘written submissions’’ section below.
Written Submissions
In lieu of or in addition to appearing
at the hearing, interested parties are
invited to file written submissions
concerning this investigation. All
written submissions should be
addressed to the Secretary, and should
be received not later than 5:15 p.m.,
February 29, 2016. All written
submissions must conform with the
provisions of section 201.8 of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.8). Section 201.8
and the Commission’s Handbook on
Filing Procedures require that interested
parties file documents electronically on
or before the filing deadline and submit
eight (8) true paper copies by 12:00 p.m.
eastern time on the next business day.
In the event that confidential treatment
of a document is requested, interested
parties must file, at the same time as the
eight paper copies, at least four (4)
additional true paper copies in which
the confidential information must be
deleted (see the following paragraph for
further information regarding
confidential business information).
Persons with questions regarding
electronic filing should contact the
Office of the Secretary, Docket Services
Division (202–205–1802).
Any submissions that contain
confidential business information must
also conform with the requirements of
section 201.6 of the Commission’s Rules
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
of Practice and Procedure (19 CFR
201.6). Section 201.6 of the rules
requires that the cover of the document
and the individual pages be clearly
marked as to whether they are the
‘‘confidential’’ or ‘‘non-confidential’’
version, and that the confidential
business information is clearly
identified by means of brackets. All
written submissions, except for
confidential business information, will
be made available for inspection by
interested parties.
The Commission may include some or
all of the confidential business
information submitted in the course of
this investigation in the report it sends
to the USTR. Additionally, all
information, including confidential
business information, submitted in this
investigation may be disclosed to and
used: (i) By the Commission, its
employees and Offices, and contract
personnel (a) for developing or
maintaining the records of this or a
related proceeding, or (b) in internal
investigations, audits, reviews, and
evaluations relating to the programs,
personnel, and operations of the
Commission including under 5 U.S.C.
Appendix 3; or (ii) by U.S. government
employees and contract personnel (a)
for cybersecurity purposes or (b) in
monitoring user activity on U.S.
government classified networks. The
Commission will not otherwise disclose
any confidential business information in
a manner that would reveal the
operations of the firm supplying the
information.
E:\FR\FM\19JAN1.SGM
19JAN1
2907
Federal Register / Vol. 81, No. 11 / Tuesday, January 19, 2016 / Notices
Summaries of Written Submissions
The Commission intends to publish
summaries of the positions of interested
persons. Persons wishing to have a
summary of their position included in
the report should include a summary
with their written submission. The
summary may not exceed 500 words,
should be in MSWord format or a format
that can be easily converted to MSWord,
and should not include any confidential
business information. The summary will
be published as provided if it meets
these requirements and is germane to
the subject matter of the investigation.
The Commission will identify the name
of the organization furnishing the
summary and will include a link to the
Commission’s Electronic Document
Information System (EDIS) where the
full written submission can be found.
By order of the Commission.
Issued: January 12, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016–00771 Filed 1–15–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Lipomed, Inc.
ACTION:
Notice of registration.
Lipomed, Inc. applied to be
registered as an importer of certain basic
classes of controlled substances. The
Drug Enforcement Administration
(DEA) grants Lipomed, Inc. registration
as an importer of those controlled
substances.
SUMMARY:
By notice
dated June 25, 2015, and published in
the Federal Register on July 6, 2015, 80
FR 38468, Lipomed, Inc., One
Broadway, Cambridge, Massachusetts
02142 applied to be registered as an
importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
SUPPLEMENTARY INFORMATION:
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of
Lipomed, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of controlled substances:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Controlled substance
Schedule
Cathinone (1235) .................................................................................................................................................................................
Methcathinone (1237) .........................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) (1248) ............................................................................................................................
N-Ethylamphetamine (1475) ...............................................................................................................................................................
N,N-Dimethylamphetamine (1480) ......................................................................................................................................................
Fenethylline (1503) ..............................................................................................................................................................................
Aminorex (1585) ..................................................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) ................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...................................................................................................................................................
Methaqualone (2565) ..........................................................................................................................................................................
Mecloqualone (2572) ...........................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) ..........................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008) ........................................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) ..............................................................................................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) (7081) ..........................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) .............................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl) indole) (7118) .....................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) (7122) .............................................................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173) ...............................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200) .................................................................................................
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) (7201) .............................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) (7203) ..............................................................................................................
Alpha-ethyltryptamine (7249) ..............................................................................................................................................................
Ibogaine (7260) ...................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) .........................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) ...................................................
Lysergic acid diethylamide (7315) ......................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) (7348) ......................................................................................................
Marihuana (7360) ................................................................................................................................................................................
Tetrahydrocannabinols (7370) ............................................................................................................................................................
Parahexyl (7374) .................................................................................................................................................................................
Mescaline (7381) .................................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) (7385) ....................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ......................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ......................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ....................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole (7398) ...............................................................................................................
2,5-Dimethoxy-4-ethylamphetamine (7399) ........................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ............................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine (7401) ..........................................................................................................................
VerDate Sep<11>2014
17:50 Jan 15, 2016
Jkt 238001
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
E:\FR\FM\19JAN1.SGM
19JAN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 81, Number 11 (Tuesday, January 19, 2016)]
[Notices]
[Pages 2904-2907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-00771]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 332-556]
Generalized System of Preferences: Possible Modifications, 2015
Review
AGENCY: United States International Trade Commission.
ACTION: Notice of institution of investigation and scheduling of public
hearing.
-----------------------------------------------------------------------
SUMMARY: Following receipt of a request on December 30, 2015, from the
United States Trade Representative (USTR), the U.S. International Trade
Commission (Commission) instituted investigation No. 332-556,
Generalized System of Preferences: Possible Modifications, 2015 Review,
for the purpose of providing advice and information relating to the
possible designation of additional articles, removal of articles, and
waiver of competitive need limitations.
DATES:
February 1, 2016: Deadline for filing requests to appear at the
public hearing.
February 3, 2016: Deadline for filing pre-hearing briefs and
statements.
February 24, 2016: Public hearing.
February 29, 2016: Deadline for filing post-hearing briefs and
statements.
February 29, 2016: Deadline for filing all other written
submissions.
April 28, 2016: Transmittal of Commission report to the United
States Trade Representative.
ADDRESSES: All Commission offices, including the Commission's hearing
rooms, are located in the United States International Trade Commission
Building, 500 E Street SW., Washington, DC. All written submissions
should be addressed to the Secretary, United States International Trade
Commission, 500 E Street SW., Washington, DC 20436. The public record
for this investigation may be viewed on the Commission's electronic
docket (EDIS) at https://www.usitc.gov/secretary/edis.htm.
FOR FURTHER INFORMATION CONTACT: Information specific to this
investigation may be obtained from Mahnaz Khan, Project Leader, Office
of Industries (202-205-2046 or mahnaz.khan@usitc.gov), Jessica
Pugliese, Deputy Project Leader, Office of Industries (202-205-3064 or
jessica.pugliese@usitc.gov), or Cynthia Foreso, Technical Advisor,
Office of Industries (202-205-3348 or cynthia.foreso@usitc.gov). For
information on the legal aspects of this investigation, contact William
Gearhart of the Commission's Office of the General Counsel (202-205-
3091 or william.gearhart@usitc.gov). The media should contact Margaret
O'Laughlin, Office of External Relations (202-205-1819 or
margaret.olaughlin@usitc.gov). Hearing-impaired individuals may obtain
information on this matter by contacting the Commission's TDD terminal
at 202-205-1810. General information concerning the Commission may also
be obtained by accessing its Web site (https://www.usitc.gov). Persons
with mobility impairments who will need special assistance in gaining
access to the Commission should contact the Office of the Secretary at
202-205-2000.
Background
In his letter, the USTR requested the advice and information
described below.
(1) Advice concerning the probable economic effect of elimination
of U.S. import duties on certain articles from all beneficiary
developing countries under the GSP program. In accordance with sections
503(a)(1)(A), 503(e), and 131(a) of the Trade Act of 1974, as amended
(``the 1974 Act'') (19 U.S.C. 2463(a)(1)(A), 2463(e), and 2151(a)), and
pursuant to the authority of the President delegated to the USTR by
sections 4(c) and 8(c) and (d) of Executive Order 11846 of March 31,
1975, as amended, and pursuant to section 332(g) of the Tariff Act of
1930 (19 U.S.C. 1332(g)), the USTR notified the Commission that the
articles identified in Table A of the Annex to the USTR request letter
are being considered for designation as eligible articles for purposes
of the GSP program. The USTR requested that the
[[Page 2905]]
Commission provide its advice as to the probable economic effect on
total U.S. imports, U.S. industries producing like or directly
competitive articles, and on U.S. consumers of the elimination of U.S.
import duties on the articles identified in Table A of the Annex to the
USTR request letter for all beneficiary developing countries under the
GSP program (see Table A below).
(2) Advice concerning the probable economic effect of elimination
of U.S. import duties on certain handbags and travel goods products for
least-developed beneficiary developing countries (LDBDCs) and certain
African Growth and Opportunity (AGOA) countries. In accordance with
sections 503(a)(1)(B), 503(e), 506A(b)(1), and 131(a) of the 1974 Act,
and pursuant to the authority of the President delegated to the USTR by
sections 4(c) and 8(c) and (d) of Executive Order 11846 of March 31,
1975, as amended, and pursuant to section 332(g) of the Tariff Act of
1930, the USTR notified the Commission that certain handbags and travel
goods products identified in Table A of the Annex to the USTR request
letter are also being considered for designation as eligible articles
for countries designated as least-developed beneficiary developing
countries (LDBDCs) and for countries listed in section 107 of the
African Growth and Opportunity Act (AGOA) (19 U.S.C. 3706). The USTR
requested that the Commission provide its advice as to the probable
economic effect on total U.S. imports, U.S. industries producing like
or directly competitive articles, and on U.S. consumers of the
elimination of U.S. import duties on certain handbag and travel goods
products identified in Table A for LDBDCs, AGOA beneficiary developing
countries, and both LDBDCs and AGOA beneficiary developing countries
combined under the GSP program (see Table A below).
Table A--Possible Additions to the List of Products Eligible for the GSP
Eligible Products
------------------------------------------------------------------------
HTS Subheading or
statistical reporting number Brief description Country(ies)
------------------------------------------------------------------------
2204.21.20.................. Effervescent wine... Beneficiary
Developing
Countries.
3301.13.00.................. Essential oils of Beneficiary
lemon. Developing
Countries.
7202.11.50.................. Ferromanganese Beneficiary
containing by Developing
weight more than 4 Countries.
percent of carbon.
4202.11.00; 4202.11.00.30; Certain handbags and Beneficiary
4202.11.00.90; 4202.12.40; travel goods Developing
4202.21.60; 4202.21.90; products. Countries, Less
4202.22.15; 4202.22.45; Developed
4202.31.60; 4202.32.40; Beneficiary
4202.32.80; 4202.92.15; Developing
4202.92.20; 4202.92.45; countries, and AGOA
4202.99.90; 4202.12.20.20; countries.
4202.12.20.50;
4202.12.80.30;
4202.12.80.70;
4202.22.80.50;
4202.32.95.50;
4202.32.95.60;
4202.91.00.30;
4202.91.00.90.
------------------------------------------------------------------------
(3) Advice concerning the probable economic effect of removal of
certain articles from specified countries from eligibility for duty-
free treatment. The USTR notified the Commission that certain articles
are being considered for removal from eligibility for duty free
treatment under the GSP program from specified countries. Under
authority delegated by the President, pursuant to section 332(g) of the
Tariff Act of 1930, with respect to articles listed in Table B of the
Annex to the USTR request letter, the USTR requested that the
Commission provide its advice as to the probable economic effect of the
removal from eligibility for duty-free treatment under the GSP program
for such articles from the specified country on total U.S. imports,
U.S. industries producing like or directly competitive articles, and on
U.S. consumers (see Table B below).
Table B--Possible Removals From Duty-Free Status From the Specified
Country for a Product on the List of Eligible Articles for the GSP
------------------------------------------------------------------------
HTS Subheading Brief description Country
------------------------------------------------------------------------
3204.20.10.................. Fluorescent India and Indonesia.
brightening agent
32.
3204.20.80.................. Other fluorescent India and Indonesia.
brightening agents.
3907.60.00.................. PET resin India.
(polyethylene
terephthalate in
primary forms).
3920.62.00.................. Nonadhesive plates, Brazil.
sheets, film, foil
and strip,
noncellular, of
polyethylene
terephthalate.
3921.90.40.................. Nonadhesive plates, Brazil.
sheets, film, foil
and strip,
flexible, nesoi, of
noncellular
plastics.
------------------------------------------------------------------------
(4) Advice concerning waiver of certain competitive need
limitations. Under authority delegated by the President, pursuant to
section 332(g) of the Tariff Act of 1930, and in accordance with
section 503(d)(1)(A) of the 1974 Act, the USTR requested that the
Commission provide advice on whether any industry in the United States
is likely to be adversely affected by a waiver of the competitive need
limitations specified in section 503(c)(2)(A) of the 1974 Act for the
countries and articles specified in Table C of the attached Annex to
the request letter (see Table C below). Further, in accordance with
section 503(c)(2)(E) of the 1974 Act, the USTR requested that the
Commission provide its advice with respect to whether like or directly
competitive products were being produced in the United States on
January 1, 1995. The USTR also requested that the Commission provide
its advice as to the probable economic effect on total U.S. imports, as
well as on consumers, of the requested waivers. With respect to the
competitive need limit in section 503(c)(2(A)(i)(I) of the 1974 Act,
the USTR requested that the
[[Page 2906]]
Commission use the dollar value limit of $170,000,000.
Table C--Possible Waivers of the CNL From a Specific Country
------------------------------------------------------------------------
HTS Subheading Brief description Country
------------------------------------------------------------------------
0804.10.60.................. Dates, fresh or Tunisia.
dried, whole,
without pits,
packed in units
weighing over 4.6
kg.
1509.10.40.................. Virgin olive oil and Tunisia.
its fractions,
whether or not
refined, not
chemically
modified, weighing
with the immediate
container 18 kg or
over.
2102.20.60.................. Single-cell micro- Brazil.
organisms, dead,
excluding yeasts,
(but not including
vaccines of heading
3002).
2202.90.90.................. Nonalcoholic Thailand.
beverages, nesi,
not including fruit
or vegetable juices
of heading 2009.
2804.29.00.................. Rare gases, other Ukraine.
than argon.
4202.92.04.................. Insulated beverage Philippines.
bag w/outer surface
textiles, interior
only flexible
plastic container
storing/dispensing
beverage thru
flexible tubing.
6911.10.37.................. Porcelain or china Indonesia.
(o/than bone china)
household table &
kitchenware in sets
in which aggregate
val. of arts./U.S.
note 6(b) o/$56 n/o
$200.
8708.50.95.................. Parts & accessories India.
of motor vehicle of
8701, nesoi, 8702
and 8704-8705, half-
shafts.
------------------------------------------------------------------------
Time for reporting, HTS detail, portions of report to be
classified. As requested by the USTR, the Commission will provide the
requested advice and information by April 28, 2016. The USTR asked that
the Commission issue, as soon as possible thereafter, a public version
of the report containing only the unclassified information, with any
confidential business information deleted. As requested, the Commission
will provide its advice and statistics (profile of the U.S. industry
and market and U.S. import and export data) and any other relevant
information or advice separately and individually for each U.S.
Harmonized Tariff Schedule subheading for all products subject to the
request. The USTR indicated that those sections of the Commission's
report and working papers that contain the Commission's advice and
assessment will be classified as ``confidential.'' The USTR also stated
that his office considers the Commission's report to be an inter-agency
memorandum that will contain pre-decisional advice and be subject to
the deliberative process privilege.
Public Hearing
A public hearing in connection with this investigation will be held
at the U.S. International Trade Commission Building, 500 E Street SW.,
Washington, DC, beginning at 9:30 a.m. on February 24, 2016. Requests
to appear at the public hearing should be filed with the Secretary no
later than 5:15 p.m., February 1, 2016. All pre-hearing briefs and
statements should be filed no later than 5:15 p.m., February 3, 2016;
and all post-hearing briefs and statements should be filed no later
than 5:15 p.m., February 29, 2016. All requests to appear, and pre- and
post-hearing briefs and statements should be filed in accordance with
the requirements of the ``written submissions'' section below.
Written Submissions
In lieu of or in addition to appearing at the hearing, interested
parties are invited to file written submissions concerning this
investigation. All written submissions should be addressed to the
Secretary, and should be received not later than 5:15 p.m., February
29, 2016. All written submissions must conform with the provisions of
section 201.8 of the Commission's Rules of Practice and Procedure (19
CFR 201.8). Section 201.8 and the Commission's Handbook on Filing
Procedures require that interested parties file documents
electronically on or before the filing deadline and submit eight (8)
true paper copies by 12:00 p.m. eastern time on the next business day.
In the event that confidential treatment of a document is requested,
interested parties must file, at the same time as the eight paper
copies, at least four (4) additional true paper copies in which the
confidential information must be deleted (see the following paragraph
for further information regarding confidential business information).
Persons with questions regarding electronic filing should contact the
Office of the Secretary, Docket Services Division (202-205-1802).
Any submissions that contain confidential business information must
also conform with the requirements of section 201.6 of the Commission's
Rules of Practice and Procedure (19 CFR 201.6). Section 201.6 of the
rules requires that the cover of the document and the individual pages
be clearly marked as to whether they are the ``confidential'' or ``non-
confidential'' version, and that the confidential business information
is clearly identified by means of brackets. All written submissions,
except for confidential business information, will be made available
for inspection by interested parties.
The Commission may include some or all of the confidential business
information submitted in the course of this investigation in the report
it sends to the USTR. Additionally, all information, including
confidential business information, submitted in this investigation may
be disclosed to and used: (i) By the Commission, its employees and
Offices, and contract personnel (a) for developing or maintaining the
records of this or a related proceeding, or (b) in internal
investigations, audits, reviews, and evaluations relating to the
programs, personnel, and operations of the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S. government employees and contract
personnel (a) for cybersecurity purposes or (b) in monitoring user
activity on U.S. government classified networks. The Commission will
not otherwise disclose any confidential business information in a
manner that would reveal the operations of the firm supplying the
information.
[[Page 2907]]
Summaries of Written Submissions
The Commission intends to publish summaries of the positions of
interested persons. Persons wishing to have a summary of their position
included in the report should include a summary with their written
submission. The summary may not exceed 500 words, should be in MSWord
format or a format that can be easily converted to MSWord, and should
not include any confidential business information. The summary will be
published as provided if it meets these requirements and is germane to
the subject matter of the investigation. The Commission will identify
the name of the organization furnishing the summary and will include a
link to the Commission's Electronic Document Information System (EDIS)
where the full written submission can be found.
By order of the Commission.
Issued: January 12, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016-00771 Filed 1-15-16; 8:45 am]
BILLING CODE 7020-02-P
